Kinnevik AB
Latest statistics and disclosures from Kinnevik AB's latest quarterly 13F-HR filing:
- Top 5 stock holdings are RXRX, and represent 100.00% of Kinnevik AB's stock portfolio.
- Kinnevik AB has $66M in assets under management (AUM), dropping by -3.56%.
- Central Index Key (CIK): 0001766574
Tip: Access up to 7 years of quarterly data
Positions held by Kinnevik AB consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Kinnevik AB
Kinnevik AB holds 1 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Recursion Pharmaceuticals Cl A (RXRX) | 100.0 | $66M | 13M | 4.88 |
|
Past Filings by Kinnevik AB
SEC 13F filings are viewable for Kinnevik AB going back to 2021
- Kinnevik AB 2025 Q3 filed Nov. 4, 2025
- Kinnevik AB 2025 Q2 filed Aug. 13, 2025
- Kinnevik AB 2025 Q1 filed April 28, 2025
- Kinnevik AB 2024 Q4 filed Jan. 23, 2025
- Kinnevik AB 2024 Q3 filed Oct. 15, 2024
- Kinnevik AB 2024 Q2 filed July 8, 2024
- Kinnevik AB 2024 Q1 filed April 15, 2024
- Kinnevik AB 2023 Q4 filed Feb. 2, 2024
- Kinnevik AB 2023 Q3 filed Oct. 6, 2023
- Kinnevik AB 2023 Q2 filed July 25, 2023
- Kinnevik AB 2023 Q1 filed April 14, 2023
- Kinnevik AB 2022 Q4 filed Feb. 1, 2023
- Kinnevik AB 2022 Q3 filed Oct. 25, 2022
- Kinnevik AB 2022 Q2 filed Aug. 8, 2022
- Kinnevik AB 2022 Q1 filed May 12, 2022
- Kinnevik AB 2021 Q4 filed Feb. 14, 2022